Clinical trial · Observational
Intensity-modulated Radiation Therapy From 70Gy to 80Gy in Localized Prostate Cancer
NCT02974231CI-TRIAL-00024913completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The objective is to report outcomes,including grade ≥2 overall late rectal and urinary toxicity and biochemical control rates in patients treated with IMRT (70 gy, 74 Gy and 80 Gy)
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Prostate Cancer | Malignant Prostate Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Intensity-modulated radiation therapy | Radiation | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- grade≥ 2 overall late rectal 5 years after the end of radiotherapy
- timeFrame
- 60 months
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: Consecutive patients from June 2000 to December 2010 with * untreated histologically confirmed adenocarcinoma of the prostate * stage T1c-T4 N0 M0 according to the 1992 American Joint Committee on Cancer staging system Exclusion Criteria: * Patients with positive pelvic lymphadenectomy or radiological positives nodes
References
Publications (0)
Data not yet available
No reference posted for this study.